Scarica l'app Stockscreener
4.93
2.71%
0.13
Dopo l'orario di chiusura:
4.93
Precedente Chiudi:
$4.80
Aprire:
$4.84
Volume 24 ore:
802.12K
Relative Volume:
1.83
Capitalizzazione di mercato:
$87.07M
Reddito:
-
Utile/perdita netta:
$-30.54M
Rapporto P/E:
-3.1806
EPS:
-1.55
Flusso di cassa netto:
$-18.30M
1 W Prestazione:
+4.23%
1M Prestazione:
+23.56%
6M Prestazione:
+724.41%
1 anno Prestazione:
+1,107%
Intervallo 1D:
$4.84
$5.34
Intervallo di 1 settimana:
$4.325
$5.34
Portata 52W:
$0.3916
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
Nome
Unicycive Therapeutics Inc
Settore
Industria
Telefono
650-384-0642
Indirizzo
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Confronta UNCY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
4.93 | 80.54M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Guggenheim | Buy |
| 2024-04-04 | Iniziato | Piper Sandler | Overweight |
Unicycive Therapeutics Inc Borsa (UNCY) Ultime notizie
What analysts say about Unicycive Therapeutics Inc stockAI-Driven Market Analysis & Invest With Confidence - earlytimes.in
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
Did You Lose Money on Unicycive Therapeutics, Inc. (UNCY)? Levi & Korsinsky Urges Investors to Act Before October 14, 2025 - Newsfile
When Will Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Turn A Profit? - Yahoo Finance
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
The Gross Law Firm Reminds Unicycive Therapeutics, Inc. - GlobeNewswire
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Unicycive Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsUNCY - MarketScreener
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
The Gross Law Firm Reminds Unicycive Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCY - GlobeNewswire Inc.
Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain OfficersUNCY - PR Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - The AI Journal
UNICYCIVE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics, Inc.(UNCY) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Class Action Alert: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of October 14, 2025 Deadline - ACCESS Newswire
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to ... - Caledonian Record
Join Class Action to Recover Losses from Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Recover Investment Losses: Class Action Initiated Against Unicycive Therapeutics, Inc. (UNCY) - ACCESS Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
UNICYCIVE REMINDER: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
UNCY Stockholders Have Opportunity to Lead Unicycive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
Unicycive Therapeutics' (UNCY) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Investors in Unicycive Therapeutics, Inc. Should Contact - GlobeNewswire
Shareholders SueWallSt in New Class Action Against Unicycive Therapeutics, Inc.Act Now - Nasdaq
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for InvestorsContact The Gross Law Firm - Barchart.com
UNCY Investors have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
Investors in Unicycive Therapeutics, Inc. (UNCY): Protect Your RightsContact Levi & Korsinsky Before October 14, 2025 - Newsfile
UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
Holzer & Holzer, LLC Reminds Investors of Upcoming October - GlobeNewswire
Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, Inc. (UNCY) Class ActionContact Levi & Korsinsky - Newsfile
Important Notice to Long-Term Shareholders of Humana Inc. - GlobeNewswire
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Sahm
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky Before October 14, 2025 to Join Class Action - ACCESS Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What machine learning models say about Unicycive Therapeutics Inc.July 2025 Market Mood & Precise Buy Zone Tips - newser.com
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive - The National Law Review
Securities Fraud Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY)Levi & Korsinsky Reminds Investors of October 14, 2025 - ACCESS Newswire
Unicycive Therapeutics: Interview With Founder & CEO Dr. Shalabh Gupta About The Kidney Therapy Company - Pulse 2.0
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
Unicycive Therapeutics Inc Azioni (UNCY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):